Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone for Lung Cancer Chemoprevention
NCT00780234Phase 2Completed
- Sponsor
- VA Office of Research & Development
- Start
- Aug 2009
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pioglitazone in lung cancer, sponsored by VA Office of Research & Development. Started Aug 2009; status: completed.
02
Drugs
pioglitazone
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT00780234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00780234.